Matthew J. Resnick, M.D., M.P.H.
Dr. Resnick is currently Assistant Professor of Urologic Surgery and Health Policy at Vanderbilt University Medical Center. He received his M.D. degree from the University of Pennsylvania where he completed his residency training. Dr. Resnick subsequently served as a Veterans Affairs National Quality Scholar at Vanderbilt University at which time he obtained his MPH degree. Dr. Resnick maintains an active clinical practice in genitourinary oncology.
Dr. Resnick’s research is focused on the effects of payment reform with respect to the appropriateness and intensity of cancer diagnosis, treatment, and survivorship. Dr. Resnick is actively investigating the implications of Medicare ACO enrollment on appropriateness of cancer screening to determine the net effect of shared savings and quality measurement on the delivery of recommended and discretionary health care services. Dr. Resnick is particularly interested in the development and deployment of novel payment models particularly related to cancer care delivery, and is actively working towards developing models for incentive alignment between primary care and specialty physicians. Dr. Resnick is interested in comparative effectiveness research and prostate cancer survivorship and has published extensively on these topics.
Dr. Resnick’s work has been published in a variety of journals including The New England Journal of Medicine, Journal of Clinical Oncology, Cancer, Journal of General Internal Medicine, American Journal of Medicine among others.